Lonika Majithia, MD
Radiation Oncology · Fairfax, VANPI 1376833624
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,150 of the $4,733 with a category attached, or 66.6%. AstraZeneca accounts for 69.4% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $3,356 and has fallen 95.1% since, to $165 in 2025.
Across 20 payments — averaging $236.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- Boston Scientific$278
- Medtec LLC$182
- Novartis$162
- Visionrt, Inc.$150
- Novocure Inc.$141
- plus $537 from 7 others
What the payments were for
- Consulting fees$3,15067%
- Food & beverage$1,58333%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 3 | $3,283 |
| Boston Scientific | 2 | $278 |
| Medtec LLC | 1 | $182 |
| Novartis | 2 | $162 |
| Visionrt, Inc. | 1 | $150 |
| Novocure Inc. | 2 | $141 |
| Elekta, Inc. | 1 | $139 |
| Sirtex Medical Inc | 1 | $110 |
| Angiodynamics, Inc. | 1 | $106 |
| Teleflex LLC | 2 | $69 |
| Siemens Medical Solutions USA, Inc. | 2 | $59 |
| Brainlab, Inc. | 1 | $40 |
| Fortovia Therapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IMFINZI$3,150
- TheraSphere Y90 Glass Microspheres 10 GBq$278
- ELEKTA MEDICAL LINEAR ACCELERATOR$139
- PLUVICTO$134
- Optune$122
- TAGRISSO$110
- SIR-Spheres Microspheres$110
- Nanoknife$106
How this compares
$4,733 in reported general payments places this provider in the 85th percentile of 121 radiation oncology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in Fairfax
- Daniel KimFairfax$406K
- Samir KananiFairfax$90K
- Gopal BajajFairfax$23K
- Ashish ChawlaFairfax$14K
- Gregory SibleyFairfax$10K
- Kevin ChoeFairfax$8K
- Harold AgbahiweFairfax$7K
- Tobias ChapmanFairfax$2K
- Kathryn MarqueenFairfax$2K
- Michael EblanFairfax$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.